ISUIA, but data was limited (16). A therapeutic advantage in posterior circulation aneurysms was apparent in large aneurysms (diameter, 13-24 mm) and poor outcomes were associated with aneurysm size and patient age (13).
█ MATERIAL and METHODS
From June 2008 to June 2011, 45 patients with acute or subacute subarachnoid hemorrhage (SAH) from ruptured posterior circulation aneurysms were evaluated for endovascular treat- █ 
INTRODUCTION
The incidence of microsurgical treatment of posterior circulation aneurysms has decreased while endovascular treatment has increased (1,3, 10, 19) , resulting from the International Study of Unruptured Intracranial Aneurysms (ISUIA) (13) , which assumed high morbidity in microsurgical patients, and the International Subarachnoid Aneurysm Trial (ISAT) that showed a more favorable neurological outcomes with endovascular treatment than that with microsurgical treatment (10) . Only 2.7% cases were posterior circulation aneurysms in ISAT and clinical outcome data was not described for these patients (10) . The perception that endovascular treatment was better for posterior circulation aneurysms may have come from ment. Their procedure reports, computed tomography (CT), magnetic resonance imaging (MRI) scans and angiograms were retrospectively reviewed. Clinical follow-up examination was supplemented by telephone interviews. All patients in this series had an acute or subacute SAH and they were classified according to Hunt and Hess grading system (4). Quantitative measurement of aneurysm size was performed with the use of a 3 dimensional (3D) workstation. The review included aneurysmal shape, degree of sac occlusion, and extent of aneurysm recurrence. During initial treatment, the angiographic projections of the aneurysm were used. The rates of aneurysm occlusion were determined in subsequent followup studies. A modification of the Raymond classification scale was used to measure aneurysm occlusion immediately after angiography (4). Clinical condition at presentation was determined by the Hunt-Hess grading system (4). Clinical outcome at follow-up was classified with the Glasgow Outcome Scale (GOS) (5). Clinical data were obtained from examinations conducted by stroke neurologists or neurosurgeons before and after the procedure. Clinical data were obtained from neurological examinations during follow-up angiographic studies, from examinations by patients' referring neurosurgeons and neurologists, and by telephone interviews. All treatment was performed under general anesthesia. A 6F arterial sheath was used in the right common femoral artery. Diagnostic angiography was performed using a 5F catheter to evaluate the aneurysm and extent of vasospasm and other cerebral vascular anomalies. When patients received endovascular treatment, one of 3 types of endovascular treatment, "simple coiling" for aneurysms with a small neck, and "deconstructive" or "reconstructive" for wide-necked aneurysms, was selected. Deconstructive treatment was performed by proximal coil occlusion or internal coil trapping of the parent artery. Reconstructive treatment was performed using 1 to 2 overlapping stents, with or without coiling. The treatment modality was decided according to the patient's presentation, aneurysm shape, and anatomy of the vertebrobasilar artery. Self-expanding neurovascular stents (Neuroform, Boston Scientifics, or Enterprise, Codman) were preferably used. Patients with stenting received a loading dose of antiplatelet premedication (300 mg of clopidogrel) for 2 hours before treatment and dual antiplatelet medication (100 mg of aspirin and 75 mg of clopidogrel) after the procedure. Dual antiplatelet medication was maintained for 4 weeks and then was changed to aspirin monotherapy indefinitely.
█ RESULTS
There were 24 men (53.3%) and 21 women (46.7%). Ages ranged from 18 to 71 years (mean age, 47.1 years). The median time of initial SAH to endovascular treatment was 5 days. Thirty-four patients (75.6%) were Hunt-Hess grade I (Figures 1A, B ; 2A, B), 3 (6.7%) grade II, 6 (13.3%) grade III ( Figure 3A , B) and 2 (4.4%) grade IV. The most prevalent aneurysm location was at the intracranial vertebral artery in 23 patients (51.1%) followed by the posterior cerebral artery in 7 patients (15.6%), basilar bifurcation in 5 patients (11.1%), basilar trunk in 5 patients (11.1%), vertebro-basilar artery junction in 4 patients (8.9%) and other location in 3 patients (6.7%) ( Table I) . Among the treated aneurysms, 6 (12.5%) were saccular with a narrow neck (<4 mm), 12 (25%) were wide-necked (>4 mm) saccular and 30 (62.5%) were fusiform aneurysms. Mean aneurysm size was 7.2±4.35 mm. On postprocedural angiogram, 38 of 48 (79.2%) aneurysms treated with coiling, parent vessel occlusion or stent-assisted coiling were occluded without remnant. Eight aneurysms treated with coiling or stent-assisted coiling showed subtotal occlusion. Eight aneurysms were subtotally occluded, 6 with residual dome filling (Raymond Class 3), the other 2 with filling of a residual base (Raymond Class 2). Contrast residual time within the aneurysm was increased moderately after the stent placement in 2 patients treated by stenting alone. In 43 of 45 patients (95.5%), excellent clinical and technical results were obtained without any procedure-related complications. There were 2 cases of minor permanent morbidity (2 of 45 (4.4%)), and no mortality. In total, 43 patients (95.5%) retained no permanent deficits and returned to their baseline neurological examination. The 2 cases of permanent minor morbidity caused by initial SAH did recover during follow-up period. Follow-up angiograms were achieved in 40 patients (88.9%) at 1 to 24 months (average 7.2 months). These 40 patients harboured 42 aneurysms. Thirty-five patients (87.5%) remained stable during the entire observation period. Five aneurysms in 5 patients showed re-canalization, all of which were treated initially with stent-assisted coiling. Of the 2 aneurysms treated with stenting alone, follow-up angiography was obtained, which one demonstrated complete aneurysm occlusion without re-canalization and one showed no change in shape during the observation period. These included 2 vertebral artery fusiform aneurysms. Five recurrences (12.5%) required re-treatment. One vertebral artery fusiform aneurysm was recoiled and stented again at 6-month follow-up, because of delayed growth of a small pseudoaneurysm proximal to the previously treated area. Another 2 vertebral artery fusiform aneurysms in 2 patients showed re-canalization on 8-and 13 
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Although ISAT demonstrated neurological outcomes with endovascular coiling that were better than with microsurgical clipping (10) . Recent long-term follow-up of ISAT (11) have showed an increased risk of recurrent bleeding from a coiled aneurysm compared with a clipped aneurysm. The risk of death at 5 years was significantly lower in the coiled group than the clipped group. Another surgical series by Sanai et al. (17) describes the results of 217 selected aneurysms of the posterior circulation, 80.6% were ruptured. 66% of patients were determined to be neurologically intact or have mild nonlimiting deficits (GOS I and II) at 13.6-month follow-up. Of the 171 aneurysms that were clipped directly, 167 (97.7%) were eliminated angiographically. In our study, there is a higher part of good-grade patients than that of Lempert et al. (9) (7% Hunt-Hess grade IV and V versus 22%) and Sanai et al. (17) (10.6% Hunt-Hess grade IV and V versus 2.3%). In one prospective randomized trial of surgery versus endovascular therapy in 109 patients, Vanninen et al. (21) described 83% of coil-treated patients with posterior circulation aneurysm with GOS I and II scores compared with 60% of surgical patients at 3 months. Kassel et al. (7, 8) reported an overall good recovery in 52.6%, a 7.9% incidence of severely disabled/vegetative outcome and death rate of 31.2%. Other surgical series (15, 17, 19) reported mortality of 6% to 11% and morbidity of 10%. Our study is limited by the small number of cases, but it failed to detect a statistically significant difference in final outcome. -month follow-up angiograms. Re-coiling was successfully performed and further follow-up at 10 and 15 months showed no further recurrence. In the fourth retreated patient, a fusiform vertebral artery aneurysm involving the posterior inferior cerebellar artery (PICA) that was initially treated by stent and coils showed 3-mm filling of residual base to preserve the origin of the PICA. This aneurysm re-bled on postprocedure day 2 and the re-coiling with complete obliteration of the pseudoaneurysm, but leaving approximately 10% of the residual base of the aneurysm to preserve the origin of the PICA; no permanent neurological deficits were encountered. Another re-canalized basilar artery tip aneurysm was recoiled at 3-month follow-up and further follow-up at 12 months after the recoiling (15 months after the initial intervention) showed no further re-canalization. Follow-up clinical examination was achieved in all 45 patients at average 19.2 months (range from 1 to 43 months). All patients had no new post-procedural deficit and showed significant improvement in their presenting symptoms.
█ DISCUSSION
Untreated ruptured aneurysms have a 37% risk of re-bleeding at 4 weeks resulting an overall mortality and morbidity of 34% to 42% (1, 12). Our results suggested that endovascular therapy offers a protective effect contrast to this dismal natural history. One re-bleeding in the acute phase occurred after incomplete stent-assisted coiling resulting a 2.2% (1/45 patients) rate of recurrent SAH. Furthermore, no aneurysm ruptured during follow-up period. This was a rate similar to those reported in other endovascular series, which range from 0.1%/year to 3.4%/year (2,6,11,18). Johnston et al. measured the rate of recurrent SAH at 1.90% in a group of 1001 patients treated with coil embolization or surgical clipping during a follow-up period of 4 years (6).
Wermer et al. measured the cumulative incidence of recurrent SAH was 3.2% in the first 10 years after the initial SAH in a group of 752 patients treated with surgical clipping (22) . Risk factors of recurrent SAH were smoking, older age and multiple aneurysms at the time of the initial SAH. The initial clinical grade at presentation strongly predicted patient outcome (9, 14) . In one series, Hunt-Hess grade III patients predictably had a lower incidence of GOS I outcome (78%). More than 90% of Hunt-Hess grade I or II patients had a good recovery leading to a GOS I outcome at final follow-up (9) . Fewer patients recovered to a good final outcome in Hunt-Hess grade IV and V patients: GOS I outcomes were achieved in only 46% of Hunt-Hess grade IV cases and in only 25% of Hunt-Hess grade V patients (9) . Clinical deterioration that resulted from medical problems (7.3%), vasospasm (8.3%), and early and delayed complications (1.8%) have been reported (9) . Our overall final excellent clinical outcome (GOS I) was 95.6% and good (GOS II) was 4.4%. In this series, 82.2% patients were of good-grade (Hunt-Hess grade I or II) and this may associated with our favorable clinical outcomes. Contrast to 2.8% to 5.1% complication rate in other endovascular series (14, 20) , there was no procedure-related complication in our series.
